15 completed. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Completed 15 |
Follow Cellulitis: new trials by email Literature Review of Cellulitis trials Research Report on Cellulitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High-dose Cephalexin for Cellulitis (HI-DOCC) Cephalexin - Cellulitis | Phase 4 | Completed | Ottawa Hospital Research Institute | 454 | 2023-08-30 | 2026-08-03 |
| Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China test product (T) azithromycin capsule and reference product (R) azithromycin capsule "Sumamed®" - Upper Respiratory Tract Infection, Lower Respiratory Infection | Phase 4 | Completed | Peking University People's Hospital | 48 | 2022-11-16 | 2023-11-28 |
| High-dose vs. Standard-dose Cephalexin for Cellulitis Cephalexin, Cephalexin + placebo - Cellulitis | Phase 4 | Completed | Ottawa Hospital Research Institute | 69 | 2021-08-16 | 2025-01-17 |
| The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown Medicinal honey, Bacitracin - Skin Infection | Phase 4 | Completed | Henry Ford Health System | 17 | 2018-10-25 | 2026-01-07 |
| A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Oritavancin, Warfarin - Acute Bacterial Skin and Skin Structure Infection | Phase 4 | Completed | The Medicines Company | 17 | 2015-09-29 | 2023-12-20 |
| Adjunctive Clindamycin for Cellulitis: C4C Trial. Flucloxacillin, Clindamycin, Placebo oral capsule - Cellulitis | Phase 4 | Completed | University Hospitals Bristol and Weston NHS Foundation Trust | 410 | 2013-10-01 | 2022-08-17 |
| The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin Daptomycin, Vancomycin - Cellulitis | Phase 4 | Completed | Hospital Universitario Evangelico de Curitiba | 20 | 2012-07-01 | 2015-03-20 |
| Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections Daptomycin, Vancomycin - Cellulitis, Skin Infections | Phase 4 | Completed | University of Cincinnati | 104 | 2012-05-01 | 2014-08-01 |
| Study of Wound Packing After Superficial Skin Abscess Drainage Wound packing, NoPacking - Abscess, Skin Diseases, Infectious | Phase 4 | Completed | NYU Langone Health | 60 | 2008-09-01 | 2011-01-04 |
| Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. Retapamulin Ointment, 1% - Skin Infections, Bacterial | Phase 4 | Completed | GlaxoSmithKline | 60 | 2007-09-01 | 2016-12-28 |
| Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections Tigecycline, ampicillin-sulbactam - Skin Diseases, Bacterial | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 550 | 2006-09-01 | 2026-09-15 |
| RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg Penicillin VK, placebo - Cellulitis/Erysipelas of the Leg | Phase 4 | Completed | University of Nottingham | 274 | 2006-07-01 | 2012-07-24 |
| Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas Daptomycin, Vancomycin - Cellulitis | Phase 4 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 80 | 2006-02-20 | 2017-09-07 |
| A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections cefdinir, cephalexin - Mild to Moderate Uncomplicated Skin and Skin Structure Infections | Phase 4 | Completed | Abbott | 380 | 2005-03-01 | 2007-10-25 |
| Topical Therapy for Prevention of Infections in Preterm Infants Aquaphor, Sunflower Seed Oil - Skin Diseases | Phase 4 | Completed | Johns Hopkins Bloomberg School of Public Health | 600 | 2001-12-01 | 2005-09-13 |
Skin Diseases (2) · Abscess (1) · Carbuncle (1) · Folliculitis (1) · Furunculosis (1) · Impetigo (1) · Infections (1) · Lymphedema (1) · Respiratory Tract Infections (1) · Skin Abnormalities (1) · Skin Diseases, Bacterial (1) · Skin Diseases, Infectious (1) · Staphylococcal Infections (1) · Sudden Infant Death (1)
Connective Tissue Diseases (15) · Inflammation (15) · Pathologic Processes (15) · Pathological Conditions, Signs and Symptoms (15) · Skin and Connective Tissue Diseases (15) · Suppuration (15) · Infections (14) · Skin Diseases, Infectious (14) · Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Gram-Positive Bacterial Infections (3) · Skin Diseases (2) · Skin Diseases, Bacterial (2) · Staphylococcal Infections (2) · Staphylococcal Skin Infections (2)
Cephalexin (3) · Daptomycin (3) · Vancomycin (3) · Azithromycin (1) · Bacitracin (1) · Cefdinir (1) · Clindamycin (1) · Floxacillin (1) · Penicillin V (1) · Petrolatum (1) · Sunflower Oil (1) · Tigecycline (1) · Warfarin (1) · oritavancin (1) · sultamicillin (1)
Ottawa Hospital Research Institute (2) · Abbott (1) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · GlaxoSmithKline (1) · Henry Ford Health System (1) · Hospital Universitario Evangelico de Curitiba (1) · Johns Hopkins Bloomberg School of Public Health (1) · NYU Langone Health (1) · Peking University People's Hospital (1) · The Medicines Company (1) · University Hospitals Bristol and Weston NHS Foundation Trust (1) · University of Cincinnati (1) · University of Nottingham (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
United States (7) · Canada (3) · South Africa (2) · Taiwan (2) · United Kingdom (2) · Argentina (1) · Bangladesh (1) · Brazil (1) · Chile (1) · China (1) · Costa Rica (1) · Germany (1) · Hong Kong (1) · Ireland (1) · Israel (1)
Bruce Friedman, MD (1) · Gary L Darmstadt, MD (1) · George J. Shaw, MD, PhD (1) · Hywel Williams, Professor (1) · Krishan Yadav, MD (1) · Krishan Yadav, MD, MSc (1) · Seilesh Babu, MD (1)
PMID 17355677, PMID 19124814, PMID 19222623, PMID 19788787, PMID 22653459, PMID 2292525, PMID 23145952, PMID 24799810, PMID 24842503, PMID 24973422, PMID 25605319, PMID 25992781, PMID 27531595, PMID 28314743, PMID 29299899, PMID 29869364, PMID 31378847, PMID 34039435, PMID 36592299, PMID 438352